4Claure-Del Granado R, Macedo E, Chertow GM, et aL Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis[J]. Clin J Am Soc Nephrol, 2011, 6(3) :467-475.
5Prowle JR, Schneider A, Bellomo R. Clinical review: optimal dose of continuous renal replacement therapy in acute kidney injury[J]. Crit Care, 2011,15 (2) : 207.
7Tabak'ian EA, Zaruba AIu, Rogoza AN, et al. Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure [J]. Ter Arkh, 2010,82 (8) : 24-29.
6McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study [ J ]. N Engl J Med, 1971, 285(26): 1441-1446.
7Folland ED, Parisi AF, Moynihan PF, et al. Assessment of LV ejection fraction and volume by real-time two dimensional echocar-diography. A comparison of cineangiographic and radionuclide techniques[ J]. Circulation, 1979, 60(4) : 760 - 766.
8Martine Z, Rumayor A, Richards AM, et al. Biology of the natfiuretic peptides[J]. Am J Cardiol, 2008,101 (3A) : 3 -8.
9Hunt SA, Abraham WT, Chin MH, et al. ACC /AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[ J]. Circulation, 2005, 112(12) : e154 -235.
10Emdin M, Passino C, Prontera C, et al. Comparison of brain natriuretic peptide (BNP) and amio-terminal proBNP for early diagnosis of heart failure [ J]. Clinical Chemistry, 2007, 53 ( 7 ) : 1289 - 1297.
4Paterson AL, Johnston AJ, Kingston D, et al. Clinical and economic impact of a switch from high - to low - volume renal replacement thera- py in patients with acute kidney injury [ J ]. Anaesthesia, 2014,69 (9) : 977 - 982.
5Bihari S, Taylor S, Bersten AD. Inadvertent sodium loading with renal replacement therapy in critically ill patients [ J ]. J Nephrol, 2014,27 (4) :439 -444.
6Shchekochikhin D, A1 Ammary F, Lindenfeld J A, et al. Role of Diuretics and Ultrafiltration in Congestive Heart Failure[J]. Pharmaceuticals, 2013,6(7):851-866.
7Felker G M, Mentz R J. Diuretics and Ultrafiltration in Acute Decompensated Heart Failure[J]. the American College of Cardiology, 2012 Journal of 59(24):2145-2153.
8Mcmurray J J, Adamopoulos S, Anker S D, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. De- veloped in collaboration with the Heart Failure Associ- ation (HFA) of the ESC[J]. Eur J Heart Fail, 2012, 14(8): 803-869.
9Yancy C W, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/Ameri- can Heart Association Task Force on Practice Guidelines [J]. Journal of the American College of Cardiology, 2013,62(16):e147-e239.
10Costanzo M R, Saltzberg M T, Jessup M, et al. Ultrafil- tration is associated with fewer rehespitalizations than continuous diuretic infusion in patients with de- compensated heart failure: results from UNLOAD[J]. J Card Fail, 2010,16(4):277-284.
